Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
about
Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype.Dynamic Network Connectivity: A new form of neuroplasticitySpecific regulation of NRG1 isoform expression by neuronal activityCellular and synaptic mechanisms of anti-NMDA receptor encephalitisMechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disordersCircuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaMechanisms of neuregulin actionDeficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment.The neurodevelopmental hypothesis of schizophrenia, revisitedNeuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time windowSynapse-specific contributions in the cortical pathology of schizophreniaSynaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.Glutamatergic autoencephalitides: an emerging fieldPhenotypic characterization of transgenic mice overexpressing neuregulin-1Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute NeuropathologiesGenetic Consideration of Schizotypal Traits: A ReviewThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaCommon mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disordersHas an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophreniaNeuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathwayModulation of functional EEG networks by the NMDA antagonist nitrous oxideThe neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampusType III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit componentsSustained high levels of neuregulin-1 in the longest-lived rodents; a key determinant of rodent longevityExpression of the neuregulin receptor ErbB4 in the brain of the rhesus monkey (Macaca mulatta)Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoringNeuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in MiceSpatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.Neurobehavioral Differences Between Mice Receiving Distinct Neuregulin Variants as Neonates; Impact on Sensitivity to MK-801.Altered serine/threonine kinase activity in schizophreniaAnimal Models of Psychosis: Current State and Future Directions.The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis.Postmortem brain: an underutilized substrate for studying severe mental illnessAnimal models and measures of perceptual processing in schizophrenia.Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.
P2860
Q21092751-238CF20B-B0E1-4DAD-A50F-E8CBFD9067D9Q24597628-D78EBD5D-78B2-4E74-8E54-131C0B7B9D46Q24618674-2776F15E-EE61-40C0-9D21-E10D4BB7836DQ24620536-275063F2-01CB-4BD4-8D95-F5585F17A08EQ24632757-C522C6BE-17F3-4758-8378-20C8BFB70699Q24646206-EABD0F85-E5FC-4EF7-A3F5-951AE33905CCQ24650665-ED8375D4-9243-496A-BF02-504648F640BBQ24657399-D0085C56-180A-4B54-8DB3-3A5BD875315BQ24658343-121F95E3-2716-40C9-B97C-1489BFEC921EQ26823783-F50C9EC9-BCBF-46A7-B6C3-0D79DD259C77Q26825577-44A50034-E24D-4D1B-9DE5-A3CCEF2254F3Q26829347-CAE2D848-C1DF-451A-87CE-5C3994AE83C8Q26992294-BFC95C81-EAB0-4246-8EC2-A5E0EA3D5759Q27316077-EC9D34B3-A6C6-4A07-A594-33302230D5F7Q28072353-43E68E90-B530-4D6E-9476-7C6EDCC6191FQ28078642-C446BA68-9078-4DE3-815A-3B2F74F83EA9Q28081110-CE9516BF-BABB-46F6-AF25-7EE897C1540EQ28086869-C6A6E21F-FD25-46BA-820F-033ABC337908Q28275290-E27DA94B-B27F-4404-9923-E701D38F478EQ28285114-9ED0239B-5F8C-4A00-9C23-55D76DF5FEE7Q28486163-9B9B1D59-5508-4ACE-A234-B98EBC35B7DEQ28568657-5121FE64-B13E-4858-9869-41CF6D82B302Q28572389-A32A6C33-961B-43F2-B408-BF32361599D5Q28585466-786B2A9B-A34E-42AF-B2C2-C795F009B51CQ28649598-0C9DDCF9-B485-4410-B189-0C3918FDA386Q28743017-A5239430-98E4-48FB-B3AA-7C90FCBDC521Q28754716-6B2625D3-704F-4760-AA02-EB72C17B0CE6Q29541297-C95C6479-8B1F-4393-ADAC-9037B3FA9CB0Q30355619-DFC4BF02-11C5-4BEF-AB68-3961896B90BFQ30371601-3863641F-D6B8-4B71-813A-21452B56F2DCQ30387014-27106593-878F-43FE-B62F-A840591668F7Q30388341-AD2298AB-002D-4454-AE40-28F049399C9DQ30388470-6B3C7AB7-8693-439B-8000-0794AB69CA74Q30408611-09B4971E-4211-4781-812C-3745ABE8AC8BQ30409979-07C3FDFE-0AD2-4A7A-B92F-C0E97C1B9C5BQ30410153-80534322-5A2F-4E48-98B7-A05F8FB2AB2BQ30421323-676872E5-9013-4F1D-B62B-9AC188D430B1Q30422050-03047ACA-844F-49C6-AC99-40FE63F187CCQ30427273-6A463EC9-1EF6-48DB-A358-6CB2942321F6Q30454766-9FC1651D-C163-41C0-8367-045E61123D8E
P2860
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@ast
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en-gb
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@nl
type
label
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@ast
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en-gb
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@nl
prefLabel
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@ast
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en-gb
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@nl
P2093
P2860
P3181
P356
P1433
P1476
Altered neuregulin 1-erbB4 sig ...... hypofunction in schizophrenia
@en
P2093
Chang-Gyu Hahn
Dan-Sung Cho
Hoau-Yan Wang
Joshua Kamins
Kalindi Bakshi
Karin E Borgmann-Winter
Konrad Talbot
Robert J Gallop
Steven J Siegel
Wade H Berrettini
P2860
P2888
P3181
P356
10.1038/NM1418
P407
P577
2006-07-01T00:00:00Z
P5875
P6179
1021067423